中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Mitigating gut immune adverse effects in CTLA-4 blockade for antitumor efficacy

文献类型:期刊论文

作者He, Shijun2,3; Zuo, Jianping1,3; Lin, Zemin1,3
刊名SCIENCE CHINA-LIFE SCIENCES
出版日期2024-04-03
页码3
ISSN号1674-7305
DOI10.1007/s11427-024-2550-4
通讯作者Lin, Zemin(linzemin@simm.ac.cn)
资助项目National Natural Science Foundation of China[82374108] ; Shanghai Municipal Science and Technology Major Project[TM202301D003]
WOS研究方向Life Sciences & Biomedicine - Other Topics
语种英语
WOS记录号WOS:001197658500001
出版者SCIENCE PRESS
源URL[http://119.78.100.183/handle/2S10ELR8/310565]  
专题新药研究国家重点实验室
通讯作者Lin, Zemin
作者单位1.Univ Chinese Acad Sci, Sch Pharm, Beijing 100049, Peoples R China
2.Shanghai Univ Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Shanghai 201203, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
He, Shijun,Zuo, Jianping,Lin, Zemin. Mitigating gut immune adverse effects in CTLA-4 blockade for antitumor efficacy[J]. SCIENCE CHINA-LIFE SCIENCES,2024:3.
APA He, Shijun,Zuo, Jianping,&Lin, Zemin.(2024).Mitigating gut immune adverse effects in CTLA-4 blockade for antitumor efficacy.SCIENCE CHINA-LIFE SCIENCES,3.
MLA He, Shijun,et al."Mitigating gut immune adverse effects in CTLA-4 blockade for antitumor efficacy".SCIENCE CHINA-LIFE SCIENCES (2024):3.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。